Health and Fitness Health and Fitness
Mon, August 9, 2010
Fri, August 6, 2010
Thu, August 5, 2010
Wed, August 4, 2010
Tue, August 3, 2010
Mon, August 2, 2010
Fri, July 30, 2010
Thu, July 29, 2010
Wed, July 28, 2010
Tue, July 27, 2010
Mon, July 26, 2010
Fri, July 23, 2010
Thu, July 22, 2010
Wed, July 21, 2010
Tue, July 20, 2010
[ Tue, Jul 20th 2010 ] - Market Wire
00 AM EDT
Mon, July 19, 2010

Enzon to Release Second Quarter 2010 Earnings on Tuesday, August 3, 2010; Conference Call and Webcast to Follow


//health-fitness.news-articles.net/content/2010/ .. -2010-conference-call-and-webcast-to-follow.html
Published in Health and Fitness on Wednesday, July 28th 2010 at 13:11 GMT by Market Wire   Print publication without navigation


BRIDGEWATER, N.J.--([ BUSINESS WIRE ])--Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) announced today that it will report its financial results for the quarter ended June 30, 2010, on Tuesday, August 3, 2010 at 4:00 pm Eastern Time (ET). The release will be followed by a live conference call, which will begin at 5:00 pm Eastern Time (ET) on Tuesday, August 3, 2010.

All interested parties may access the call by using the following information:

Domestic Dial-In Number:

(877) 561-2748

International Dial-In Number:

(720) 545-0044

Access Code: Enzon

The call will also be available via live audio webcast at the following site: [ http://investor.enzon.com/eventdetail.cfm?eventid=84459 ]. Listeners should go to the website at least fifteen minutes before this event to download and install any necessary audio software. For those unable to attend the live audio webcast, a replay will be available beginning approximately one hour after the event. Additionally, a telephonic rebroadcast will also be available following the call. The rebroadcast will begin on Tuesday, August, 3, 2010 at approximately 8:00 pm Eastern Time (ET) and end on Tuesday, August 10, 2010 at approximately 11:59pm Eastern Time (ET). It may be accessed using the following information:

Domestic Dial-In Number:

(800) 642-1687

International Dial-In Number:

(706) 645-9291

Conference I.D.:

90977127

About Enzon

Enzon Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and development of innovative medicines for patients with cancer. Enzona™s drug development programs utilize several cutting-edge approaches, including its industry-leading PEGylation technology platform, Customized Linker technologya" and mRNA antagonists using the Locked Nucleic Acida" (LNA) technology. Enzon receives a royalty revenue stream from licensing partnerships for other products developed using the proprietary PEGylation technology. Further information about Enzon and this press release can be found on the Companya™s web site at [ www.enzon.com ].


Publication Contributing Sources